Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants

References

• Campbell P, McIntyre P, Quinn H, et al. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS One. 2012;7:e35874.
   PubMed Web of Science ®Google Scholar
• Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384:1521–1528.
   PubMed Web of Science ®Google Scholar
• Winter K, Glaser C, Watt J, et al. Centers for Disease Control and Prevention (CDC). Pertussis epidemic–California, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:1129–1132.
   PubMed Web of Science ®Google Scholar
• Mohammed H, Roberts CT, Grzeskowiak LE, et al. Safety of maternal pertussis vaccination on pregnancy and birth outcomes: A prospective cohort study. Vaccine. 2021;39:324–331.
   PubMed Web of Science ®Google Scholar
• Barug D, Pronk I, van Houten MA, et al. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in The Netherlands: an open-label, parallel, randomised controlled trial. Lancet Infect Dis. 2019;19:392–401.
   PubMed Web of Science ®Google Scholar
• Rice TF, Diavatopoulos DA, Smits GP, et al. Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom. Clin Exp Immunol. 2019;197:1–10.
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Perrett KP, Messina NL, et al. The effect of maternal immunisation during pregnancy on infant vaccine responses. EClinicalMedicine. 2019;13:21–30.
   PubMedGoogle Scholar
• Wanlapakorn N, Maertens K, Vongpunsawad S, et al. Quantity and quality of antibodies after acellular versus whole-cell pertussis vaccines in infants born to mothers who received Tetanus, Diphtheria, and Acellular Pertussis vaccine during pregnancy: a randomized trial. Clin Infect Dis. 2020;71:72–80.
   PubMed Web of Science ®Google Scholar
• Englund JA, Anderson EL, Reed GF, et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics. 1995;96:580–584.
   PubMed Web of Science ®Google Scholar
• Cabore RN, Maertens K, Dobly A, et al. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium. Virulence. 2017;8:1245–1254.
   PubMed Web of Science ®Google Scholar
• Rice TF, Diavatopoulos DA, Guo Y, et al. Modification of innate immune responses to bordetella pertussis in babies from pertussis vaccinated pregnancies. EBioMedicine. 2021;72:103612.
   PubMed Web of Science ®Google Scholar
• Orije MRP, García-Fogeda I, Van Dyck W, et al. Impact of maternal pertussis antibodies on the infants’ cellular immune responses. Clin Infect Dis. 2022;75:442–452.
   PubMed Web of Science ®Google Scholar
• PERISCOPE Consortium. PERISCOPE: road towards effective control of pertussis. Lancet Infect Dis. 2019;19:e179–e186.
   PubMed Web of Science ®Google Scholar
• van Gageldonk PG, van Schaijk FG, van der Klis FR, et al. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J Immunol Methods. 2008;335:79–89.
   PubMed Web of Science ®Google Scholar
• van Gageldonk PGM, von Hunolstein C, van der Klis FRM, et al. Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid. Clin Vaccine Immunol. 2011;18:1183–1186.
   PubMedGoogle Scholar
• Knuutila A, Versteegen P, Barkoff A-M, et al. Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups. Emerg Microbes Infect. 2022;11:956–963.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Y, Chen Z, et al. Determination of serum neutralizing antibodies reveals important difference in quality of antibodies against pertussis toxin in children after infection. Vaccine. 2021;39:1826–1830.
   PubMed Web of Science ®Google Scholar
• Versteegen P, Barkoff A-M, Valente Pinto M, et al. Memory B cell activation induced by pertussis booster vaccination in four age groups of three countries. Front Immunol. 2022;13:864674.
   PubMed Web of Science ®Google Scholar
• Hallander HO, Ljungman M, Storsaeter J, et al. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. APMIS. 2009;117:797–807.
   PubMed Web of Science ®Google Scholar
• Hallander HO, Andersson M, Gustafsson L, et al. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS. 2009;117:912–922.
   PubMed Web of Science ®Google Scholar
• Moriuchi T, Otsuka N, Hiramatsu Y, et al. A high seroprevalence of antibodies to pertussis toxin among Japanese adults: qualitative and quantitative analyses. PLoS One. 2017;12:e0181181.
   PubMed Web of Science ®Google Scholar
• Maertens K, Caboré RN, Huygen K, et al. Pertussis vaccination during pregnancy in Belgium: follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age. Vaccine. 2016;34:3613–3619.
   PubMed Web of Science ®Google Scholar
• Halperin SA, Langley JM, Ye L, et al. A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response. Clin Infect Dis. 2018;67:1063–1071.
   PubMed Web of Science ®Google Scholar
• Versteegen P, Valente Pinto M, Barkoff AM, et al. Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, The Netherlands, and the United Kingdom. EBioMedicine. 2021;65:103247.
   PubMed Web of Science ®Google Scholar
• Peer V, Muhsen K, Betser M, et al. Antibody response to pertussis vaccination in pregnant and Non-Pregnant women-The role of sex hormones. Vaccines (Basel). 2021;9:637.
   PubMed Web of Science ®Google Scholar
• Abu Raya B, Srugo I, Kessel A, et al. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study. Vaccine. 2014;32:5787–5793.
   PubMed Web of Science ®Google Scholar
• Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine. 2003;21:3406–3412.
   PubMed Web of Science ®Google Scholar
• Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol. 2014;5:446.
   PubMed Web of Science ®Google Scholar
• Van Savage J, Decker MD, Edwards KM, et al. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis. 1990;161:487–492.
   PubMed Web of Science ®Google Scholar
• Vono M, Eberhardt CS, Auderset F, et al. Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-Life B cell repertoire within germinal centers. Cell Rep. 2019;28:1773–1784.e5.
   PubMed Web of Science ®Google Scholar